SECURE DATA OFFICE: AN INDEPENDENT TEAM THAT CAN COME TO THE RESCUE IN BLINDED TRIALS

Size: px
Start display at page:

Download "SECURE DATA OFFICE: AN INDEPENDENT TEAM THAT CAN COME TO THE RESCUE IN BLINDED TRIALS"

Transcription

1 SECURE DATA OFFICE: AN INDEPENDENT TEAM THAT CAN COME TO THE RESCUE IN BLINDED TRIALS Annelies Van Zeveren, PhD Project Manager Biometrics and Medical Affairs SGS Life Science Clinical Research PhUSE US Connect 2018

2 OVERVIEW n Introduction n Secure Data Office tasks Randomisation Data The Pharmacokinetic (PK) Data flow Other unblinding data streams Cleaning of unblinding data Deliver blinded result transfers Deliver data to unblinded teams n Conclusion 2

3 OVERVIEW n Introduction n Secure Data Office tasks Randomisation Data The Pharmacokinetic (PK) Data flow Other unblinding data streams Cleaning of unblinding data Deliver blinded result transfers Deliver data to unblinded teams n Conclusion 3

4 INTRODUCTION n Double blind study: Subject and investigator are unaware of treatment status Parties without access to unblinding data: subjects, investigators, Data Management, Statistics, PK analysts, sponsor Parties with access to unblinding data: pharmacists, bio-analytical lab, unblinded CRA n Unblinding data: Any data that can unblind the study n Downside: Treatment information, Pharmacokinetic & Immunogenicity data Biomarkers.. Unblinding data is not cleaned Delay in clinical database lock or unblinding data are not included in lock Crunched timelines for some parts of the analysis 4

5 Who should handle randomisation data and other unblinding data (e.g. PK, biomarker, immunogenicity data)?

6 SD OFFICE n Dedicated team, physically separated from other study team members n Separate databases and secure server locations n Clearly defined processes in SOPs and WIs 6

7 OVERVIEW n Introduction n Secure Data Office tasks Randomisation Data The Pharmacokinetic (PK) Data flow Other unblinding data streams Cleaning of unblinding data Deliver blinded result transfers Deliver data to unblinded teams n Conclusion 7

8 RANDOMISATION DATA n Generation of randomisation lists Documented randomisation list specifications By SAS programmers with statistical background Distribution to required recipients n Support and handle of unblinding data in IWRS system n Creation of SDTM dataset containing randomisation information based on following input Subject information: from data management Receive randomisation information: from external vendor or internally created 8

9 PK DATA FLOW n PK data (Identifiers and results): Bio-analytical lab SDO n Blinded transfers: SDO DM n Cleaning is performed by DM n DM delivers clean PC file to SDO Contains CRF and sample tracking data Without results n SDO delivers clean PC file with results to include at time of database lock 9

10 1 Central lab 3 Ship sample and shipping list BAN lab Ship sample, req. Form and shipping list Investigational site Transfer ST file for reconciliation Transfer SAMPID file Transfer Results file ZOOM 1 Capture ecrf data into clinical database 5 Data management 7 Send identifier file Send clean PC without concentrati ons 6 SD Office Create merged PC 9 Complete PK flow Send locked Clinical database Create PP dataset NCA output file NCA input file Clinical Pharmacology, Pharmacometrics 10

11 1 Central lab 3 Ship sample and shipping list BAN lab Ship sample, req. Form and shipping list Investigational site Transfer ST file for reconciliation Transfer SAMPID file Transfer Results file Capture ecrf data into clinical database 5 Data management 7 Send identifier file Send clean PC without concentrati ons 6 SD Office Creation of PC dataset Create merged PC 9 11

12 1 Central lab 3 Ship sample and shipping list BAN lab Ship sample, req. Form and shipping list Investigational site Transfer ST file for reconciliation Transfer SAMPID file Transfer Results file Capture ecrf data into clinical database 5 Data management 7 Send identifier file Send clean PC without concentrati ons 6 SD Office Create merged PC 9 Complete PK flow Send locked Clinical database Create PP dataset ZOOM 2 12 NCA output file NCA input file Clinical Pharmacology, Pharmacometrics 11 12

13 CREATION OF PK INPUT FILES AND PP DATASET Create merged PC 9 Data management Send locked Clinical database 10 SD Office Create PP dataset 13 NCA output file 12 NCA input file Creation of PP dataset Clinical Pharmacology, Pharmacometrics 11 13

14 Without SD Office CREATION OF PK/PD INPUT FILES BY SDO Database lock Start programming input file Final PK/PD input (NCA/ NONMEM) file ready PK/PD modeling Results Issues in DB? DB re-opening With SD Office Start programming input file Issues in DB? Solved before DB lock Database lock PK/PD modeling Results Time Gain Final PK/PD input (NCA/ NONMEM) file ready 14

15 OTHER UNBLINDING DATA STREAMS: LAB DATA n Similar to PK data stream n Only unblinding analytes via SDO n SDTM domains: LB, PD, IS n DM unblinded at release Yes: combine LB parts by DM No: combine LB parts and release by SDO 15

16 OTHER UNBLINDING DATA STREAMS: PROTOCOL DEVIATIONS n Identification of unblinding protocol deviations (usually medication kit errors) Protocol deviation defined as Any medication kit misallocation Only treatment misallocations Medication kit number unblinding? Y SD Office involved SD Office involved N Detection of medication kit misallocations by data management SD Office involved 16

17 OTHER UNBLINDING DATA STREAMS: PROTOCOL DEVIATIONS n Assigned medkit = planned data n Dispensed medkit = actual data n Reconciliation of planned and actual data by SDO n SDO creates part of the DV domain: Deviations related to medkit or treatment misallocations 17

18 CLEANING OF UNBLINDING DATA n Only if cleaning of the unblinding content is required n Cleaning requirements: in secure data handling plan n Cleaning Checks are: Defined Documented Programmed Validated Ran n Review output of checks n Write and follow up queries: blinded/unblinded 18

19 DELIVER BLINDED RESULT TRANSFERS TO BLINDED TEAMS n PK data (Identifiers and results), other unblinding data: external vendor SDO n Blinded transfers: SDO Data Management (DM) n Cleaning is performed by DM n Results transfer with dummy identifiers/scrambled: SDO Statistics, PK analysts: dry runs 19

20 DELIVER DATA TO UNBLINDED TEAMS n PK data (Identifiers and results), other unblinding data: external vendor SDO n Blinded transfers: SDO Data Management (DM) n Cleaning is performed by DM n Results transfer with real production data: SDO Safety commitee, DRC, Statistical Support Group (SSG) 20

21 OVERVIEW n Introduction n Secure Data Office tasks Randomisation Data The Pharmacokinetic (PK) Data flow Other unblinding data streams Cleaning of unblinding data Deliver blinded result transfers Deliver data to unblinded teams n Conclusion 21

22 CONCLUSION n Role of SD Office Create randomisation lists and datasets Clean data before database lock PK data Medication kit misallocations Other unblinding data Prepare input files for PK/PD analysis upfront -> analysis can start earlier n Results Time gain after database lock Higher quality Unblinded data available before database lock for DRC, SSG, dry runs Off the critical path and key results can be met 22

23 THANK YOU FOR YOUR ATTENTION Questions? Meet us at the SGS booth 5 clinicalresearch@sgs.com EUROPE: AMERICAS: JOIN THE SCIENTIFIC COMMUNITY CONNECT ON LINKEDIN 23

24 Agriculture, Food and Life Clinical Research Annelies Van Zeveren Project Director Biometrics and Medical Affairs SGS Belgium NV Phone: Life Science Fax: Generaal De Wittelaan 19a bus 5 annelies.vanzeveren@sgs.com 2800 Mechelen Web : Belgium Meet us at the SGS booth 5 clinicalresearch@sgs.com EUROPE: AMERICAS: JOIN THE SCIENTIFIC COMMUNITY CONNECT ON LINKEDIN 24

AUTOMATED SDTM CREATION AND DISCREPANCY DETECTION JOBS: THE NUMBERS TELL THE TALE. Joris De Bondt PhUSE Conference Oct 2014

AUTOMATED SDTM CREATION AND DISCREPANCY DETECTION JOBS: THE NUMBERS TELL THE TALE. Joris De Bondt PhUSE Conference Oct 2014 AUTOMATED SDTM CREATION AND DISCREPANCY DETECTION JOBS: THE NUMBERS TELL THE TALE Joris De Bondt PhUSE Conference 2014 12-15 Oct 2014 OUTLINE n Setting the scene SGS Conversion Center SDTM data sources

More information

EDC integrations. Rob Jongen Integration Technology & Data Standards

EDC integrations. Rob Jongen Integration Technology & Data Standards EDC integrations Rob Jongen Integration Technology & Data Standards Past, Present and Future Past (10 years back) Few sources, all on paper Source data copied on paper CRF Data entry from CRF to clinical

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

Examining Rescue Studies

Examining Rescue Studies White Paper Examining Rescue Studies Introduction The purpose of this White Paper is to define a Rescue Study, outline the basic assumptions, including risks, in setting up such a trial based on DATATRAK

More information

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials

From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials PhUSE 2014 Paper PP05 From ODM to SDTM: An End-to-End Approach Applied to Phase I Clinical Trials Alexandre Mathis, Department of Clinical Pharmacology, Actelion Pharmaceuticals Ltd., Allschwil, Switzerland

More information

RDC Roles and Responsibilities RDC has several basic roles that are available to users that enter, update, review and approve data. Site User Data Entry Responds to queries Principal Investigator Reviews

More information

One Project, Two Teams: The Unblind Leading the Blind

One Project, Two Teams: The Unblind Leading the Blind ABSTRACT PharmaSUG 2017 - Paper BB01 One Project, Two Teams: The Unblind Leading the Blind Kristen Reece Harrington, Rho, Inc. In the pharmaceutical world, there are instances where multiple independent

More information

esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES

esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES esource Initiative ISSUES RELATED TO NON-CRF DATA PRACTICES ISSUES RELATED TO NON-CRF DATA PRACTICES Introduction Non-Case Report Form (CRF) data are defined as data which include collection and transfer

More information

BioInformatics A Roadmap To Success. Data Management Plans. Wes Rountree Associate Director of Data Management Family Health International

BioInformatics A Roadmap To Success. Data Management Plans. Wes Rountree Associate Director of Data Management Family Health International BioInformatics A Roadmap To Success Data Management Plans Wes Rountree Associate Director of Data Management Family Health International What is a Data Management Plan? A document that describes how clinical

More information

Purpose: To describe the requirements for managing IP at the clinical site

Purpose: To describe the requirements for managing IP at the clinical site Title: Investigational Product Management Topic: Management of IP Effective Date: March 16, 2016 Approved By: Rita Hanson, M.D. Senior VP/Chief Medical Officer Purpose: To describe the requirements for

More information

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.

More information

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China

Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China PharmaSUG China 2018 - Paper 73 Best Practices for E2E DB build process and Efficiency on CDASH to SDTM data Tao Yang, FMD K&L, Nanjing, China Introduction of each phase of the trial It is known to all

More information

How to review a CRF - A statistical programmer perspective

How to review a CRF - A statistical programmer perspective Paper DH07 How to review a CRF - A statistical programmer perspective Elsa Lozachmeur, Novartis Pharma AG, Basel, Switzerland ABSTRACT The design of the Case Report Form (CRF) is critical for the capture

More information

UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE

UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)

More information

PharmaSUG Paper PO03

PharmaSUG Paper PO03 PharmaSUG 2012 - Paper PO03 Streamlining Regulatory Submission with CDISC/ADaM Standards for Nonstandard Pharmacokinetic/Pharmacodynamic Analysis Datasets Xiaopeng Li, Celerion Inc., Lincoln, NE (USA)

More information

Automate Clinical Trial Data Issue Checking and Tracking

Automate Clinical Trial Data Issue Checking and Tracking PharmaSUG 2018 - Paper AD-31 ABSTRACT Automate Clinical Trial Data Issue Checking and Tracking Dale LeSueur and Krishna Avula, Regeneron Pharmaceuticals Inc. Well organized and properly cleaned data are

More information

PharmaSUG Paper PO22

PharmaSUG Paper PO22 PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT

More information

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA

More information

An Introduction to Analysis (and Repository) Databases (ARDs)

An Introduction to Analysis (and Repository) Databases (ARDs) An Introduction to Analysis (and Repository) TM Databases (ARDs) Russell W. Helms, Ph.D. Rho, Inc. Chapel Hill, NC RHelms@RhoWorld.com www.rhoworld.com Presented to DIA-CDM: Philadelphia, PA, 1 April 2003

More information

IRT & ecoa: The Good, The Bad & The Ugly YPrime, inc. All Rights Reserved

IRT & ecoa: The Good, The Bad & The Ugly YPrime, inc. All Rights Reserved What we would like to share: Overview of the concept of IRT and ecoa integration Benefits and challenges of scanning in an integrated system Using an integrated system for drug accountability and reconciliation

More information

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets PharmaSUG 2017 - Paper SS09 Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets Xiangchen (Bob) Cui, Min Chen, and Letan (Cleo) Lin, Alkermes Inc.,

More information

Discrepancy Statuses In OC RDC PDF Discrepancy Management Window:

Discrepancy Statuses In OC RDC PDF Discrepancy Management Window: Discrepancy Statuses In OC RDC PDF Discrepancy Management Window: While working in OC RDC, you will encounter discrepancies with various assigned statuses on the Discrepancy Management window. The statuses

More information

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Pooling Clinical Data: Key points and Pitfalls October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Introduction Are there any pre-defined rules to pool clinical data? Are there any pre-defined

More information

Standard Operating Procedure Clinical Data Management

Standard Operating Procedure Clinical Data Management P-CTU-010 Standard Operating Procedure Topic area: Data Management and Statistics Based on SCTO Matrix: Not applicable Identification number: P-CTU-010 Version: /- Valid from: 01.06.2014 Review and Approval

More information

OC RDC 4.6. User Guide

OC RDC 4.6. User Guide OC RDC 4.6 Read-Only User Guide Version 1.0 Page 1 of 25 TABLE OF CONTENTS ACCESSING OC RDC...3 Steps for Obtaining Access...3 Logging On...4 Password Changes...5 Computer System and Security...5 VIEWING

More information

Standard Operating Procedure. SOP effective: 06 February 2017 Review date: 06 February 2019

Standard Operating Procedure. SOP effective: 06 February 2017 Review date: 06 February 2019 Standard Operating Procedure SOP number: SOP full title: SOP-JRO-26-001 Data Management SOP effective: 06 February 2017 Review date: 06 February 2019 SOP author signature: SIGNED COPY HELD WITHIN THE NJRO

More information

Michael Duvenhage / Tarun Bhatnagar. 08 Aug 2018

Michael Duvenhage / Tarun Bhatnagar. 08 Aug 2018 Michael Duvenhage / Tarun Bhatnagar 08 Aug 2018 Agenda Dataflow and regional collection strategies (3 options) Data Management Tasks Data collection hot zone considerations Data sharing agreements Safety

More information

Discrepancy Management

Discrepancy Management Discrepancy Management While working in OC RDC, you will encounter discrepancies with various assigned statuses. The description of each type of status is listed below. Unreviewed This is the Unreviewed

More information

OC RDC HTML User Guide

OC RDC HTML User Guide CRA - Monitor OC RDC 4.5.3 HTML User Guide Page 1 of 46 TABLE OF CONTENTS Accessing OC RDC Steps for Access Logging On Change Password Computer and System Security Study and Site 3 4 5 5 6 Navigating OC

More information

Clinical trial data management technology Guide

Clinical trial data management technology Guide annex Clinical trial data management technology Guide I. Overview Clinical Trial Data quality is evaluated on the basis of clinical trial results. In order to ensure accurate and reliable results of clinical

More information

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA

Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA PharmaSUG 2015 - Paper IB09 Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA ABSTRACT A submission to FDA for an NDA (New Drug Application) or

More information

User Guide 16-Mar-2018

User Guide 16-Mar-2018 16-Mar-2018 This document is freely distributable Identification Authors Name Organization Title TMF User Guide and Implementation Guide Sub-Team Version History Version Steering Committee Approval Date

More information

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA Paper FC02 SDTM, Plus or Minus Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT The CDISC Study Data Tabulation Model (SDTM) has become the industry standard for the regulatory submission

More information

A Simple Interface for defining, programming and managing SAS edit checks

A Simple Interface for defining, programming and managing SAS edit checks Paper PP07 A Simple Interface for defining, programming and managing SAS edit checks Virginie Freytag, Clin Data Management, Rouffach, France Michel Toussaint, Clin Data Management, Rouffach, France ABSTRACT

More information

Discrepancy Management

Discrepancy Management Discrepancy Management Oracle Clinical Discrepancy Statuses IN OC RDC Discrepancies tab: While working in OC RDC Classic, you will encounter discrepancies with various assigned statuses on the Discrepancies

More information

D4.2 Data Management System

D4.2 Data Management System D4.2 Data Management System 116019 - RESCEU REspiratory Syncytial virus Consortium in EUrope WP4 Prospective data collection Lead contributor Other contributors Louis Bont (3 UMCU) l.bont@umcutrecht.nl

More information

Implementing targeted Source Data Verification (SDV) Strategy in idatafax

Implementing targeted Source Data Verification (SDV) Strategy in idatafax Implementing targeted Source Data Verification (SDV) Strategy in idatafax Sadia Yousuf Research Coordinator, Population Health Research Institute DFUG 2017, Orlando, Florida Source Data Verification (SDV)

More information

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop

Taming the SHREW. SDTM Heuristic Research and Evaluation Workshop Taming the SHREW SDTM Heuristic Research and Evaluation Workshop September 13, 2013 Carlo Radovsky 2 Overview Introductions The Backstory CDISC IntraChange History of a Rule The Challenge Discuss Amongst

More information

Using EDC System: Benefits, Considerations, and Challenges. March 20, 2012

Using EDC System: Benefits, Considerations, and Challenges. March 20, 2012 Benefits, Considerations, and Challenges March 20, 2012 A Quick Introduction of Merck Serono Oldest pharmaceutical company Four R&D Hubs, Geneva, Darmstadt, Boston and Beijing Focus on oncology, neurodegenerative,

More information

PharmaSUG Paper SP09

PharmaSUG Paper SP09 PharmaSUG 2013 - Paper SP09 SAS 9.3: Better graphs, Easier lives for SAS programmers, PK scientists and pharmacometricians Alice Zong, Janssen Research & Development, LLC, Spring House, PA ABSTRACT Data

More information

General Guidance for Maintaining a Regulatory Binder

General Guidance for Maintaining a Regulatory Binder General Guidance for Maintaining a Regulatory Binder Study documentation should be well organized, providing a complete and thorough history from protocol development to study completion. Maintaining a

More information

Trial Cost Analysis Trial: Knee Surgery Study Sponsor: Principal Investigator: Hillary Resendes Total Enrollment: 8

Trial Cost Analysis Trial: Knee Surgery Study Sponsor: Principal Investigator: Hillary Resendes Total Enrollment: 8 Total Site Resources Available Coordinator Rate = $50.00 CRA Rate = $45.00 Investigator Rate = $300.00 Site Director Rate = $65.00 Trial Participation Fees Administration Institutional IT Fee $500.00 IRB

More information

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Paper DH05 How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Judith Goud, Akana, Bennekom, The Netherlands Priya Shetty, Intelent, Princeton, USA ABSTRACT The traditional

More information

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

Implementation of Data Cut Off in Analysis of Clinical Trials

Implementation of Data Cut Off in Analysis of Clinical Trials PharmaSUG 2018 DS19 Implementation of Data Cut Off in Analysis of Clinical Trials Mei Dey, AstraZeneca, USA Ann Croft, ARC Statistical Services Ltd, UK ABSTRACT Interim analysis can result in key decisions

More information

Lex Jansen Octagon Research Solutions, Inc.

Lex Jansen Octagon Research Solutions, Inc. Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,

More information

Standardising The Standards The Benefits of Consistency

Standardising The Standards The Benefits of Consistency Paper DH06 Standardising The Standards The Benefits of Consistency Nathan James, Roche Products Ltd., Welwyn Garden City, UK ABSTRACT The introduction of the Study Data Tabulation Model (SDTM) has had

More information

Standard Operating Procedure. Data Management. Adapted with the kind permission of University Hospitals Bristol NHS Foundation Trust

Standard Operating Procedure. Data Management. Adapted with the kind permission of University Hospitals Bristol NHS Foundation Trust Data Management REFERENCE: VERSION NUMBER: 2.1 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager; Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director

More information

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008

The Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits

More information

Reducing SAS Dataset Merges with Data Driven Formats

Reducing SAS Dataset Merges with Data Driven Formats Paper CT01 Reducing SAS Dataset Merges with Data Driven Formats Paul Grimsey, Roche Products Ltd, Welwyn Garden City, UK ABSTRACT Merging different data sources is necessary in the creation of analysis

More information

Demystifying Laboratory Data Reconciliation. The issues at hand

Demystifying Laboratory Data Reconciliation. The issues at hand Demystifying Laboratory Data Reconciliation Heather M. Irish and Huiming (Sam) Tu Premier Research Group, plc The issues at hand Why lab data is a necessary evil Why lab data gives us nightmares Holes

More information

Why organizations need MDR system to manage clinical metadata?

Why organizations need MDR system to manage clinical metadata? PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed

More information

Standard Operating Procedure. SOP full title: Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions

Standard Operating Procedure. SOP full title: Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions Standard Operating Procedure SOP number: SOP full title: SOP-JRO-03-003 Sponsor processes for reporting Suspected Unexpected Serious Adverse Reactions SOP effective: 23/05/2017 Review date: 23/05/2019

More information

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA PharmaSUG 2018 - Paper EP15 Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA Ellen Lin, Wei Cui, Ran Li, and Yaling Teng Amgen Inc, Thousand Oaks, CA ABSTRACT The

More information

Data Collection & Management

Data Collection & Management Data Collection & Management Investigator Meetings 1 st and 2 nd September 2016 - London and Leeds Jamie Godsall Data Manager, BCTU CRF return rates Form Time point Forms expected Forms received Percentage

More information

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Vicki Seyfert-Margolis, PhD Senior Advisor, Science Innovation and Policy Food and Drug Administration IOM Sharing Clinical Research

More information

Document Version: 1.0. Purpose: This document provides an overview of IBM Clinical Development v released by the IBM Corporation.

Document Version: 1.0. Purpose: This document provides an overview of IBM Clinical Development v released by the IBM Corporation. Release Notes IBM Clinical Development Release Date: 17 August 2018 Document Version: 10 OVERVIEW Purpose: This document provides an overview of IBM Clinical Development released by the IBM Corporation

More information

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China

Automation of SDTM Programming in Oncology Disease Response Domain Yiwen Wang, Yu Cheng, Ju Chen Eli Lilly and Company, China ABSTRACT Study Data Tabulation Model (SDTM) is an evolving global standard which is widely used for regulatory submissions. The automation of SDTM programming is essential to maximize the programming efficiency

More information

Chapter 10: Regulatory Documentation

Chapter 10: Regulatory Documentation Table of Contents Chapter 10: Regulatory Documentation... 10-1 10.1 Regulatory Requirements:... 10-1 10.2 Ongoing Regulatory Documents:... 10-4 10.3 After study completion or termination of the trial...

More information

SAS Training BASE SAS CONCEPTS BASE SAS:

SAS Training BASE SAS CONCEPTS BASE SAS: SAS Training BASE SAS CONCEPTS BASE SAS: Dataset concept and creating a dataset from internal data Capturing data from external files (txt, CSV and tab) Capturing Non-Standard data (date, time and amounts)

More information

Standard Operating Procedure (SOP) OPTIMISE II Database User Guide SOP 007

Standard Operating Procedure (SOP) OPTIMISE II Database User Guide SOP 007 ` Standard Operating Procedure (SOP) OPTIMISE II Database User Guide SOP 007 Authors: Priyanthi Dias & Ann Thomson Authorisation: Rupert Pearse (Chief Investigator) Scope To provide guidance on the data

More information

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AGENDA 1. Motivation 2. Automation Overview 3. Architecture 4. Validating the System 5. Pilot Study Results 6. Future State Copyright 2012-2017

More information

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM Ajay Gupta, PPD INTRODUCTION + TIBCO Spotfire is an analytics and business intelligence platform, which enables data visualization in

More information

Johannes Ulander. Standardisation and Harmonisation Specialist S-Cubed. PhUSE SDE Beerse,

Johannes Ulander. Standardisation and Harmonisation Specialist S-Cubed. PhUSE SDE Beerse, Towards better data Johannes Ulander Standardisation and Harmonisation Specialist S-Cubed PhUSE SDE Beerse, 2017-11-28 Agenda What is data? Current state of submissions Introduction to linked data and

More information

Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards

Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards Bay Area CDISC Network: PhUSE Working Group for Inspection Site Selection Data Standards Patricia Gerend Genentech, Inc., A Member of the Roche Group 30 April 2015 Agenda Page 2 Introduction to PhUSE Working

More information

InForm Functionality Reference Manual for Sites. Version 1.0

InForm Functionality Reference Manual for Sites. Version 1.0 InForm Functionality Reference Manual for Sites Version 1.0 1-Mar-2012 2012 by Merck & Co., Inc., Whitehouse Station, New Jersey, USA All Rights Reserved No part of this book may be reproduced in any form

More information

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

PhUSE Paper SD09. Overnight Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland Paper SD09 "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland ABSTRACT This demonstration shows how legacy data (in any format)

More information

SAS CLINICAL SYLLABUS. DURATION: - 60 Hours

SAS CLINICAL SYLLABUS. DURATION: - 60 Hours SAS CLINICAL SYLLABUS DURATION: - 60 Hours BASE SAS PART - I Introduction To Sas System & Architecture History And Various Modules Features Variables & Sas Syntax Rules Sas Data Sets Data Set Options Operators

More information

ALEA instructions for Local Investigators

ALEA instructions for Local Investigators ALEA instructions for Local Investigators This document provides instructions, guidelines and background information for Local Investigators (LI) regarding the Electronic Data Capture (EDC) system of ALEA,

More information

Standards Metadata Management (System)

Standards Metadata Management (System) Standards Metadata Management (System) Kevin Lee, MarkLogic COPYRIGHT 2015 MARKLOGIC CORPORATION. ALL RIGHTS RESERVED. Agenda Regulatory Requirement on Clinical Trial Standards(i.e., CDISC and ectd) Standards

More information

Key. General. Host Account Functionality. Included, no-cost Not Included Add-on/Low cost $ Add-on/High cost $$$

Key. General. Host Account Functionality. Included, no-cost Not Included Add-on/Low cost $ Add-on/High cost $$$ Key Included, no-cost Not Included Add-on/Low cost $ Add-on/High cost $$$ General X Cost $ $ $$$ $$$ Complete cross-functionality between native mobile app and web-based system Ability to create host accounts

More information

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc.

Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc. PharmaSUG2011 - Paper DM03 Data Edit-checks Integration using ODS Tagset Niraj J. Pandya, Element Technologies Inc., NJ Vinodh Paida, Impressive Systems Inc., TX ABSTRACT In the Clinical trials data analysis

More information

Legacy to SDTM Conversion Workshop: Tools and Techniques

Legacy to SDTM Conversion Workshop: Tools and Techniques Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often

More information

Release Notes IBM Clinical Development v (formerly eclinicalos) Release Date: 03 February 2017

Release Notes IBM Clinical Development v (formerly eclinicalos) Release Date: 03 February 2017 Development v201710 Document Version: 10 Release Notes IBM Clinical Development v201710 (formerly eclinicalos) Release Date: 03 February 2017 OVERVIEW Purpose: This document provides an overview of IBM

More information

CRA OC RDC Classic User Guide

CRA OC RDC Classic User Guide CRA OC RDC Classic User Guide Version 1.0 Page 1 of 37 TABLE OF CONTENTS Accessing OC RDC Steps for Access 3 Logging On 3 Change Password 5 Change Study 5 Laptop and System Security 6 Navigating OC RDC

More information

Topics Raised by EFPIA. Webinar on Policy Jun 2017, FINAL. Presentation

Topics Raised by EFPIA. Webinar on Policy Jun 2017, FINAL. Presentation Topics Raised by EFPIA Webinar on Policy 70 29 Jun 2017, FINAL Presentation Definition of listings out of scope of Phase 1 Examples Topics to discuss Previously submitted studies in scope Reiterating EFPIA

More information

Advanced Visualization using TIBCO Spotfire and SAS

Advanced Visualization using TIBCO Spotfire and SAS PharmaSUG 2018 - Paper DV-04 ABSTRACT Advanced Visualization using TIBCO Spotfire and SAS Ajay Gupta, PPD, Morrisville, USA In Pharmaceuticals/CRO industries, you may receive requests from stakeholders

More information

Annual Report 2017 (Jan. Dec.) April 3, 2018 Japan CRO Association

Annual Report 2017 (Jan. Dec.) April 3, 2018 Japan CRO Association Annual Report 2017 (Jan. Dec.) April 3, 2018 Japan CRO Association 1 JCROA 2017 Total Number of Members: 37 companies Regular Member: 16 companies Supporting Member: 21 companies (Note) * The business

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

Study Data Reviewer s Guide Completion Guideline

Study Data Reviewer s Guide Completion Guideline Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on

More information

Traceability Look for the source of your analysis results

Traceability Look for the source of your analysis results Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,

More information

InForm for Primary Investigators Performing esignature Only (v4.6) Narration

InForm for Primary Investigators Performing esignature Only (v4.6) Narration InForm for Primary Investigators Performing esignature Only (v4.6) Narration Page 1: Title Slide No narration Page 2: Welcome Welcome to the InForm for Primary Investigators Performing esignature Only

More information

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1

Reporting & Visualisation : D un Dun standard maison au format CDISC 02/02/2016 CDISC GUF 1 Reporting & Visualisation : D un Dun standard maison au format CDISC Jérémy MAMBRINI Florence WAGER 02/02/2016 CDISC GUF 1 Contents CDISC Implementation ti at SERVIER Reporting & Visualisation using CDISC

More information

October p. 01. GCP Update Data Integrity

October p. 01. GCP Update Data Integrity p. 01 p. 02 p. 03 failures by organizations to: apply robust systems that inhibit data risks, improve the detection of situations where data reliability may be compromised, and/or investigate and address

More information

Comprehensive Capabilities Comparison

Comprehensive Capabilities Comparison page 1 of 9 Comprehensive Capabilities Comparison General Key Included, no added cost Add-on/Low cost $ Not Available X Add-on/High cost $$$ Cost $ $ $$$ $$$ Complete cross-functionality between native

More information

How to clean up dirty data in Patient reported outcomes

How to clean up dirty data in Patient reported outcomes Paper DH02 How to clean up dirty data in Patient reported outcomes Knut Mueller, UCB Schwarz Biosciences, Monheim, Germany ABSTRACT The current FDA Guidance for Industry - Patient Reported Outcome Measures

More information

Pooling strategy of clinical data

Pooling strategy of clinical data Pooling strategy of clinical data Abraham Yeh, Xiaohong (Grace) Zhang, Shin-Ru Wang, Novartis Pharmaceuticals Corporation, East Hanover, NJ ABSTRACT Pooling of clinical data is used by all pharmaceutical

More information

Integrated Safety Reporting Anemone Thalmann elba - GEIGY Ltd (PH3.25), Basel

Integrated Safety Reporting Anemone Thalmann elba - GEIGY Ltd (PH3.25), Basel ntegrated Safety Reporting Anemone Thalmann elba - GEGY Ltd (PH3.25), Basel Abstract: Most of the regulatory health authorities approving pharmaceutical products consider the ntegrated Safety Summary to

More information

Version 11, JAN2017. Regulatory Document Approval Parameters for WebDCU TM POINT. People Document Collection REGULATORY REQUIREMENTS

Version 11, JAN2017. Regulatory Document Approval Parameters for WebDCU TM POINT. People Document Collection REGULATORY REQUIREMENTS Regulatory Approval Parameters for WebDCU TM Collection Person Role CV Study Drug Recipient, Secondary SC within document 5 yrs. from effective Required for all site personnel who are directly involved

More information

This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.

This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

Argus to Oracle Clinical SAE Reconciliation. Dipti Kadam. DBMS Consulting 12 October 2010 Argus Focus Group Session 14

Argus to Oracle Clinical SAE Reconciliation. Dipti Kadam. DBMS Consulting 12 October 2010 Argus Focus Group Session 14 Argus to Oracle Clinical SAE Reconciliation Dipti Kadam DBMS Consulting 12 October 2010 Argus Focus Group Session 14 Agenda Background: SAE Reconciliation Benefits of Clinical Data Systems and Safety Data

More information

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies

More information

Introduction to CDASH

Introduction to CDASH Introduction to CDASH Rhonda Facile, CDISC Melissa Binz, Wyeth Presented by Melissa Binz Director Central Standards Group, Wyeth 1 Introduction to the CDASH Standard Monday, March 16 2009 Welcome and Review

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Protocol development SOP number: TM 010 SOP category: Trial Management Version number: 03 Version date: 16 December 2016 Effective date: 16 January 2017 Revision due date: 16 January

More information

CRF Design for Data Standards. David A. Scocca

CRF Design for Data Standards. David A. Scocca CRF Design for Data Standards David A. Scocca dave_scocca@rhoworld.com CRF Design for Data Standards Controlled Terminology Epochs and Dispositions Dates and Times Free Text Fields Avoiding Unwanted Data

More information

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up

ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up ODM The Operational Efficiency Model: Using ODM to Deliver Proven Cost and Time Savings in Study Set-up Mark Wheeldon, CEO, Formedix Bay Area User Group Meeting, 15 th July 2010 Who are we? Proven Business

More information

SAS (Statistical Analysis Software/System)

SAS (Statistical Analysis Software/System) SAS (Statistical Analysis Software/System) Clinical SAS:- Class Room: Training Fee & Duration : 23K & 3 Months Online: Training Fee & Duration : 25K & 3 Months Learning SAS: Getting Started with SAS Basic

More information

Now let s take a look

Now let s take a look 1 2 3 4 Manage assets across the end to end life cycle of your studies This includes forms, datasets, terminologies, files, links and more, for example: - Studies may contain the protocol, a set of Forms,

More information